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ABSTRACT We have isolated a 4.785 Da protein from the nacreous layer of the sea snail Haliotis laevigata (greenlip abalone)
shell after demineralization with acetic acid. The sequence of 41 amino acids was determined by Edman degradation supported
by mass spectrometry. The most abundant amino acids were cysteine (19.5%), histidine (17%), and arginine (14.6%). The
positively charged amino acids were almost counterbalanced by negatively charged ones resulting in a calculated isoelectric
point of 7.86. Atomic-force microscopy studies of the interaction of the protein with calcite surfaces in supersaturated calcium
carbonate solution or calcium chloride solution showed that the protein bound speciﬁcally to calcite steps, inhibiting further
crystal growth at these sites in carbonate solution and preventing crystal dissolution when carbonate was substituted with
chloride. Therefore this protein was named perlinhibin. X-ray diffraction investigation of the crystal after atomic-force microscopy
growth experiments showed that the formation of aragonite was induced on the calcite substrate around holes caused by
perlinhibin crystal-growth inhibition. The strong interaction of the protein with calcium carbonate was also shown by vapor
diffusion crystallization. In the presence of the protein, the crystal surfaces were covered with holes due to protein binding and
local inhibition of crystal growth. In addition to perlinhibin, we isolated and sequenced a perlinhibin-related protein, indicating
that perlinhibin may be a member of a family of closely related proteins.
INTRODUCTION
The various biominerals deposited by invertebrates invari-
ably contain small amounts of an organic matrix consisting
of proteins, glycoproteins, and polysaccharides (1,2). The or-
ganic matrix is believed to control crystal nucleation, ori-
entation, size, and phase. The soluble matrix of mollusk shells
is known to contain components that inhibit crystal growth,
probably by binding to steps and kinks of crystal surfaces
that are the preferred sites of crystal growth (3,4). However,
only very few components of the matrix were characterized
at the molecular level and molecular mechanisms are largely
unknown.
The shell of the abalone consists of .95% of calcium
carbonate, which is deposited as calcite in the outer (pris-
matic) layer of the shell and as aragonite in the inner (nacre-
ous) layer (5,6). The organic matrix of the two layers contains
different sets of proteins, which, in vitro, induce the crys-
tallization of the same calcium carbonate polymorph with
which they were originally associated and modify the growth
of crystals (7,8). Some abalone nacre proteins were puriﬁed
and characterized. These are comprised of the multidomain
protein lustrin A (9), thought to be a component of the adhe-
sive between nacre mineral tablets (10); C-type lectin perlucin,
which promotes CaCO3 crystal nucleation in vitro (11);
perlustrin, a small growth factor-binding protein (12); and
perlwapin, a protein containing three whey-acidic protein do-
mains and which binds to calcite steps in vitro, inhibiting
crystal growth (13). Furthermore, the acidic nacre proteins
AP7, AP8a/b and AP24 have been isolated and were shown
to interact with speciﬁc calcite surface structures (14,15).
Here we report the isolation and sequence analysis of
perlinhibin, a new protein from abalone (Haliotis laevigata)
nacre, and perlinhibin-related protein that showed a sequence
identity to perlinhibin of 67.5%. Furthermore, the inﬂuence
of perlinhibin on calcium carbonate crystallization was in-
vestigated using the atomic force microscope (AFM) to study
the binding of perlinhibin to calcite surfaces in aqueous
solution and by the ammonium carbonate vapor diffusion
technique.
MATERIALS AND METHODS
Protein puriﬁcation and sequence analysis
The aragonitic layer of H. laevigata shells was decalciﬁed with acetic acid
and the soluble proteins were separated by ion exchange chromatography
(16). This yielded a mixture of small proteins which was further separated by
reversed phase HPLC using a short C4 column (214TP5405, 4.6 3 50 mm;
Vydac, Columbia, MD) with a gradient of 10–80% solvent B (70% ace-
tonitrile in 0.1% triﬂuoroacetic acid) in 60 min at a ﬂow rate of 0.5 ml/min.
The resulting peaks were searched for new proteins by N-terminal sequence
analysis. Before determination of complete sequences, the puriﬁed proteins
were dissolved (1 mg/ml) in 0.1 M Tris, pH 8.5, 6 M guanidinium hy-
drochloride and reduced with 10 ml mercaptoethanol for 6 h at 50C. After
cooling to room temperature 20 ml vinylpyridine was added and the mixture
was kept at room temperature in the dark overnight. Reagents and buffer
were removed by reversed phase HPLC as above. Perlinhibin was cleaved
with cyanogen bromide in 70% formic acid by addition of a small crystal of
CNBr and incubation at room temperature overnight in the dark. The frag-
ments were separated using a Superdex Peptide column (HR10/30; Pharmacia
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Biotech, Uppsala, Sweden) in 0.1% triﬂuoroacetic acid, 25% acetonitrile, at
a ﬂow rate of 0.3 ml/min. The perlinhibin-related protein was cleaved with
endoproteinase Arg-C (sequencing grade; Roche Molecular Biochemicals,
Indianapolis, IN) in 0.1 M ammonium hydrogen carbonate, 4 M urea, 5 mM
dithiothreitol, 0.5 mMEDTA, at an enzyme to substrate ratio of 1:100 for 6 h
at 23C. The resulting fragments were separated by reversed phase HPLC
using a C18 column (238TP53, 3.23 250 mm; Vydac) with a linear gradient
of 5–60% solvent B in 160 min at a ﬂow rate of 0.25 ml/min. Proteins and
fragments were sequenced using sequencers 473 A and 492 Z (Applied
Biosystems, Foster City, CA). Electrospray ionization mass spectrometry
was done with an API 365 (PE Sciex, Foster City, CA).
Preparation of saturated calcium carbonate
Saturated CaCO3 solution was prepared according to Hillner et al. (17).
Thirty to ﬁfty milliliters of 100 mMNaHCO3 was added slowly to 120 ml of
40 mM CaCl2 with continuous stirring until the solution started to become
turbid. The ﬁnal pH was adjusted to 8.2 with 1 M NaOH. The solution was
ﬁltered sterile through a ﬁlter with pores of 0.22 mm (Durapore 0.22 mm
membrane ﬁlter; Millipore, Billerica, MA) and 0.02% NaN3 was added to
prevent microbial growth.
Perlinhibin in saturated calcium carbonate and
sodium chloride solution
Eight milliliters of perlinhibin solution, stored in 20 mM citrate buffer (pH
4.8), was concentrated in a speed vac concentrator (Savant Speed Vac;
Schu¨tt Labortechnik, Go¨ttingen, Germany) to a ﬁnal volume of ;2 ml and
dialyzed three times against 100 ml of saturated CaCO3 solution at 4C. The
dialysis tubing (Spectra/Por Membrane MWCO: 6–8.000; Spectrum Med-
ical Industries, Houston, TX) was boiled in 7 mM EDTA (Karl Roth,
Karlsruhe, Germany) for 5 min and then rinsed several times with deionized
water before use. Protein concentration was determined with the Bradford
microassay (Bio-Rad Laboratories, Hercules, CA) using IgG and BSA as
standard proteins (Sigma Aldrich Chemie, Munich, Germany) and adjusted
to 0.02 mg perlinhibin/ml.
For experiments under dissolution-promoting conditions, freeze-dried
perlinhibin was dissolved in a sterile 7.5 mM CaCl2 solution, pH 7.5, to a
ﬁnal concentration of 0.2 mg/ml and stored at 4C.
AFM imaging
AFM imaging was performed in contact-mode with a commercial system
(Nanoscope IIIaMultimode; Digital Instruments, Santa Barbara, CA) equipped
with a piezoelectric scanner. Silicon nitride (Si3N4) cantilevers (Microlevers;
Park Scientiﬁc Instruments, Sunnyvale, CA) with oxide-sharpened tips were
used after treatment with UV light for 10 min to destroy organic contam-
inants on the tip. Cantilevers with a nominal force constant of 0.01 N/m were
chosen for imaging. The glass ﬂuid cell and the silicon O-ring were cleaned
with a speciﬁc detergent (Ultra Joy; Procter & Gamble, Cincinnati, OH),
rinsed with deionized water and dried with compressed nitrogen before
experiments.
Freshly cleaved calcite surfaces for AFM investigations [4 4 1 plane]
were cut from a block of geological calcite of optical quality (Creel, Mexico;
Kristalldruse, Munich, Germany) using a razor blade. The calcite crystals
were handled with tweezers to avoid contamination of the surface and ex-
amined with an optical microscope. Fragments that presented a ﬂat surface
were glued with two-component epoxy glue (Bindulin-Werk; H.L. Scho¨nleber,
Fu¨rth, Germany) onto clean mica plates that had been glued onto a magnetic
steel disk before (12 mm diameter). The dry calcite sample was carefully
rinsed with deionized water to remove calcite dust particles from the cleav-
age site before it was positioned at the top of the scanner. Deionized water,
saturated CaCO3 solution (pH 8.2), or 7.5mM CaCl2 solution with and
without perlinhibin, were injected directly into the ﬂuid cell using a 1-ml,
ﬁne dosage syringe (Injekt-F 1mL; Braun,Melsungen, Germany). All solutions
were degassed and adjusted to room temperature before use to prevent the
formation of air bubbles in the ﬂuid cell during imaging. All AFM deﬂection
images were processed with the freeware analysis software Image SXM
(Ver. 1.74) for contrast adjustment and examination of height proﬁle.
X-ray diffraction
After AFM investigation, the calcite crystal incubated with the calcium
carbonate solution supplemented with perlinhibin (0.02 mg/ml) was dried at
room temperature and carefully removed from the sample holder. The re-
sulting crystal (size;1.53 1.53 1 mm) was investigated by x-ray diffrac-
tion without any further modiﬁcation, with the previously AFM-investigated
surface on top, using Cu Ka radiation in Bragg-Brentano geometry.
Crystallization experiments with ammonium
carbonate vapor diffusion technique
The experiments were performed following a standard procedure (4). Glass
cover slides were cleaned in a solution of 70% H2SO4 and 30% H2O2 for 20
min, then rinsed several times with deionized water in an ultrasonicator,
dried in an oven at 100C and ﬁnally cooled down to room temperature
before use. The cover slides were placed in a Nunc multidish (Nalge Nunc,
Rochester, NY). Perlinhibin, stored in 20 mM citrate buffer (pH 4.8), was
dialyzed three times (Spectra/Por Membrane MWCO: 6–8.000; Spectrum
Medical Industries) at 4C against a 7.5 mM CaCl2 solution adjusted to pH
7.5 with 1 M NaOH. The ﬁnal protein concentration was adjusted to 0.02
mg/ml. Wells containing the cover slides were ﬁlled with the perlinhibin
solution. As a control, a well was ﬁlled with 800ml of 7.5 mMCaCl2 (pH 7.5).
The Nunc multidish was covered with a hole-dotted aluminum foil to
slow down diffusion and put into an airtight desiccator (volume 25l) con-
taining a beaker ﬁlled with ammonium carbonate. After ﬁve days of in-
cubation at room temperature, the cover slides were gently rinsed with
deionized water and dried at room temperature. The solutions were ﬁltered
sterile before use (Durapore 0.22 mm membrane ﬁlter; Millipore). Scanning
electron microscope (SEM) investigation was performed using a Camscan
Series 2 system (Cambridge Scientiﬁc Instruments, Ely, UK). The cover
slides were glued on SEM stubs and sputter-coated with gold. Sputtering was
performed with an Emitech K550 system (EM Technologies, Bonneville,
FR) with a current of 10–20 mA in a 0.2 mbar argon atmosphere. SEM in-
vestigation was carried out at 20 kV in secondary or back-scattered electron
imaging mode.
RESULTS
Isolation and amino-acid sequence
of perlinhibin
Perlinhibin was isolated by reversed phase chromatography
from the soluble matrix fraction, which also contained perlucin
and perlustrin (11,16). The protein eluted as one of the ﬁrst
peaks and was shown by amino-acid sequence analysis to be
pure. The yield was ;3 mg/shell. Mass determination of the
new protein by ESI-MS yielded a major peak with a mass of
4785.2 Da and a less intense peak with a mass of 4800.8 Da
(Fig. 1). The difference of 15.6 Da between these two peaks
suggested the heavier species to be an oxidation product of
the lighter one. These masses indicated a length of 40–45
amino acids for this novel polypeptide. This is a length that
can normally be sequenced in a single Edman degradation
run. However, with this peptide the repetitive yield decreased
dramatically after Pro33 (see Fig. 3) and a signiﬁcant overlap
into the next cycles developed and made an unequivocal
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identiﬁcation of the rest of the sequence impossible. Because
of these difﬁculties the reduced and pyridylethylated protein
was cleaved with CNBr and the cleavage products were sep-
arated from each other by size exclusion chromatography
using a Superdex Peptide column. The separation yielded
three peaks (Fig. 2). The ﬁrst peak showed a mass of 5649.8
Da, indicating that this was the uncleaved polypeptide with
eight pyridylethylated cysteines and that it was derived from
the oxidized native form (4800.6 Da1 83 105 Da¼ 5640.8
Da). The residual difference of 9 Da showed that the eight
cysteines formed disulﬁde bridges in the native polypeptide
(8 Da in the native form). The most plausible explanation
for the resistance of this species against CNBr cleavage was
that the oxidation inferred from mass determination had
taken place at Met25 (Fig. 3), yielding methionine sulfoxide,
which is known to inhibit CNBr cleavage. The second peak
showed a mass of 3352.8 Da, which was almost exactly the
mass calculated for the expected pyridylethylated N-terminal
fragment CB 1 (Fig. 3), 335 3Da. This was conﬁrmed by
amino acid sequence analysis. Peak 3 yielded a mass of 2251
Da and amino-acid sequence analysis conﬁrmed that it con-
tained the expected C-terminal fragment. Using modiﬁed se-
quencer cycles with cleavage temperature increased from
48C to 53C at Edman cycles corresponding to sequence
positions P33 to C36 enabled us to identify amino acids C26
to I40 (Fig. 3 A). The calculated mass for the complete
pyridylethylated sequence was 2114 Da, which was 137 Da
less than the mass determined by ESI-MS. Because this is
exactly themass of a histidine, we assumed that the C-terminal
amino acid was a histidine that had not been detected in
amino-acid sequence analysis because of the combined
overlap of His35 and His39 into the following cycles despite
of the use of modiﬁed cycles to enhance cleavage at the P33-
P34 bond. The complete sequence thus contained 41 amino
acids and the calculated mass almost exactly matched the
determined mass, assuming four disulﬁde bonds between the
eight cysteines (calculated 4785.6 Da, measured 4785.2 Da).
The most frequent amino acid in this short sequence was
cysteine with 19.5% of all amino acids, followed by histidine
with 17% and arginine with 14.6%. The positively charged ami-
no acids were almost counterbalanced by negatively charged
ones and the calculated isoelectric point was 7.86. A compar-
ison of the perlinhibin sequence to other protein sequences in
data banks did not yield a convincing match. The short,
cysteine-rich sequence aligned to other cysteine-rich sequences,
preferably to metallothionin sequences of various organisms.
Isolation and partial sequence analysis of a
perlinhibin-related polypeptide
During the puriﬁcation of another nacre protein, we found, as
one contamination of that protein among others, a polypeptide
FIGURE 1 Mass determination of native perlinhibin. The upper panel shows the measured ions, the lower panel shows the deconvoluted spectrum. The
peak at 4800.8 Da is an oxidation product of the 4785.2 Da species (see text).
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with an N-terminal amino-acid sequence very similar to that
of perlinhibin. This perlinhibin-related protein was isolated
after pyridylethylation of the mixture and rechromatography
of the pyridylethylated proteins. The yield was ;0.04 mg/
shell. Analysis of the entire sequence was complicated by the
same problems as the analysis of perlinhibin. Enzymatic cleav-
age, reversed phase HPLC, and sequence analysis of the
cleavage products yielded the amino-acid sequence shown
in Fig. 3 B, but conﬁrmation by mass spectrometry was not
possible due to the lack of material. 67.5% of the sequence,
including the eight cysteines,was identical to that of perlinhibin
(Fig. 3, B and C). However, the number of basic residues
(includingHis, which is only partially charged around neutral
pH) was reduced and the number of acidic residues was
increased.
Crystal growth inhibition by perlinhibin
The nanometer scale effect of perlinhibin on a speciﬁc calcite
surface was examined in situ by atomic force microscopy. A
freshly cleaved calcite surface ([4 4 1] plane) was incubated
with a saturated calcium carbonate solution (pH 8.2) con-
taining perlinhibin (0.02 mg/ml). The investigation was car-
ried out in contact-mode at room temperature (Fig. 4, A–H).
Visible growth of new mineral monomolecular layers (white
arrows), mostly parallel to each other, started immediately
and was followed by formation of holes, which progressively
deepened and increased in diameter, as crystal growth con-
tinued. The formation of holes (black arrows) suggested that
inhibition of mineral growth took place due to the adhesion
of perlinhibin molecules to the calcite step-edges suppress-
ing crystal growth. Step edges became therefore more frayed.
Progressive overgrowth of calcite layers surrounding the
binding sites led to a deepening of the holes and augmen-
tation of their size. A progressive convolution of the mineral
layers was also detectable (Fig. 4, G–H).
Further AFM investigations were carried out again, in-
cubating a freshly cleaved calcite surface ([4 4 1] cleavage
plane) with 0.02 mg/ml perlinhibin dissolved in a saturated
calcium carbonate solution at pH 8.2 (Fig. 4, I–L).
The cleaved calcite sample was initially imaged at room
temperature in deionized water. The surface presented sev-
eral steps, which may be due to an imperfect cleavage or to
crystal defects (Fig. 4 I). Dissolution of monomolecular
layers took place as expected. While imaging, the aqueous
solution in the ﬂuid cell was exchanged against the calcium
carbonate solution supplemented with perlinhibin. After 2
min incubation the surface appeared covered with white
spots, corresponding to single perlinhibin molecules or
protein aggregates. An initial growth of the mineral mono-
molecular layers over the preexisting one (Fig. 4 J, white
arrows) and their convolution of the step edges were again
FIGURE 2 Size exclusion chromatographic separation of perlinhibin and
its CNBr fragments. CB1 and CB2 are the N-terminal and C-terminal frag-
ments, respectively, resulting from cleavage with CNBr. U is an uncleaved
form of perlinhibin rendered resistant to CNBr cleavage from the oxidation
of its single methionine.
FIGURE 3 Amino-acid sequences of perlinhibin and perlinhibin-related
protein. Broken lines indicate the sequenced peptides obtained after cleav-
age with CNBr (CB) or endoproteinase Arg-C (R). (A) The amino-acid
sequence of perlinhibin. The C-terminal His was inferred from mass
determination. (B) The amino-acid sequence of a perlinhibin-related protein.
The last ﬁve amino acids (shown in brackets) are probable but not un-
equivocal identiﬁcations. (C) Alignment of the related sequences and the
sequence of a chemically synthesized aragonite-binding peptide from Belcher
and Gooch (6).
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detectable (Fig. 4 J). The layers initially grew mostly parallel
to each other as previously observed. After 5 h of incubation
(Fig. 4 K) the growing monomolecular layers became
conﬂuent, inducing the formation of a mostly ﬂat homog-
enous layer. The newly formed surface was again charac-
terized by deep holes (black arrows). Enhancing of the
mineral steps was visible and again suggested to be the direct
consequence of perlinhibin adhesion to calcite steps and
inhibition of calcium carbonate growth at the adhesion point.
Growth of new layers was only possible where perlinhibin
was not bound. The initial surface features were no longer
recognizable, indicating that perlinhibin caused morpholog-
ical alteration of the surface. The ﬁnal state of the newly
formed surface (after 10 h incubation, Fig. 4 L) was char-
acterized by a further increase of the holes in size, diameter,
and depth.
XRD investigation
The calcite crystal, after AFM investigation in a saturated
CaCO3 solution containing perlinhibin, was further investi-
gated by x-ray diffraction. The diffraction pattern (Fig. 5)
showed several peaks corresponding to calcite (2u ¼ 29.6),
aragonite (2u ¼ 26.48), and mica (2u ¼ 8.5, 17.4, 35.66,
and 45.14). The peak corresponding to aragonite clearly
indicated that perlinhibin induced the polymorph transition
at ambient conditions in vitro. Although, compared to the
whole crystal sample, crystal overgrowth was thin, the
aragonite peak was almost as high as the calcite peak. This
was presumably caused by the limited penetration depth of
the x rays, resulting in a diffraction pattern where crystal
parts close to the surface are emphasized. Interestingly, only
a single aragonite peak was present, whereas an aragonite
powder spectrum is composed of several peaks of similar
height. It is possible that the newly nucleated layers were at
least semioriented since they were grown on a single crys-
talline substrate. Thus they deviate from an aragonite powder
pattern. The mica peaks were induced by the sample holder,
which was used for AFM investigation.
Inhibition of crystal dissolution in calcium
chloride solution by perlinhibin
To examine the speciﬁc interaction of perlinhibin with a
calcite surface in more detail, a freshly cleaved calcite sur-
face was incubated with perlinhibin dissolved in calcium
chloride solution, which does not support crystal growth.
Freeze-dried perlinhibin was dissolved in a 7.5 mM CaCl2
solution (pH 7.5) to a ﬁnal concentration of 0.02 mg/ml.
The freshly cleaved calcite surface was initially imaged
in deionized water for several minutes (Fig. 6 A). The cal-
cite surface presented the characteristic rhombohedral voids
with a depth of ;0.40 nm, which correspond to singular
FIGURE 4 AFM investigation of the
interaction of perlinhibin with geolog-
ical calcite on a deﬁned cleavage plane
[4 4 1]. (A–H) Images of a geological
calcite surface incubated with a satu-
rated CaCO3 solution containing 0.02
mg/ml perlinhibin (frames 1 min apart).
Growth of mineral layers (white arrows)
and formation of holes (black arrows)
are shown. Due to perlinhibin adhesion
to calcite steps, the growth at these
spots is inhibited. (E) Higher magniﬁ-
cation of the area delineated in panel D
by a black rectangle. (E–H) Monomo-
lecular calcite layers grow around the
spots where perlinhibin is bound, leav-
ing holes by overgrowing the underly-
ing layers devoid of perlinhibin. (I) The
calcite surface is imaged in deionized
water. The ﬂuid cell was initially ﬁlled
with deionized water and the freshly
cleaved calcite surface was imaged
in contact-mode at room temperature.
(J–L) Calcite surface incubated with a
saturated CaCO3 solution containing
0.02 mg/ml perlinhibin (pH 8.2) at
room temperature. (J) The same sur-
face as in panel I imaged after 2 min of
incubation with saturated CaCO3 solution containing perlinhibin. Formation of new monomolecular layers over the preexisting ones is visible (white arrows).
(K) The same area imaged after 5 h. Formation of holes is visible. Hole formation (black arrows) is the direct consequence of perlinhibin adhesion to calcite
steps and ensuing inhibition of crystal growth. Mineral binding only takes place at surfaces devoid of perlinhibin. (L) Surface after 10 h incubation with
saturated CaCO3 solution and perlinhibin. Height scale: black to white, 4 nm (A–J), 70 nm (K and L).
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monomolecular calcite layers. The spontaneous dissolution
of calcium carbonate layers took place as previously observed
(17). After 20 min, the aqueous solution in the ﬂuid cell was
exchanged against the calcium chloride solution supplied
with perlinhibin. Flushing-in induced perturbations in the
ﬂuid cell and a progressive sample drift along the upper-right
direction (Fig. 6, B and C). A visible modiﬁcation of the
calcite surface took place at the edges (Fig. 6, white arrows),
while the surfaces of the layers remained unmodiﬁed. Single
perlinhibin molecules, which appeared as small white spots,
bound progressively to the crystal edges, inhibiting, at that
point, the dissolution of the layers.
During this investigation, the contours of the layers be-
came highlighted and more enhanced in the vertical direc-
tion, due to a progressive binding of the proteins at calcium
carbonate edges. Convolution of the calcite monomolecular
layer was observed again. After 25 min of incubation, visible
variations of the surface morphology were no longer detected
(Fig. 6, F–I), suggesting that perlinhibin suppressed any kind
of process taking place on the calcite surface.
By measuring the height of the ridges, we estimated
the calcite step ridge enhancement caused by adhesion of
perlinhibin molecules (Fig. 7). Where no proteins were bound,
a step height of 0.35 nm was observed, which corresponds to
the typical size of a monomolecular calcite layer. A step
enhancement of ;0.5 nm was observed at the perlinhibin
binding sites.
De novo crystal growth by vapor
diffusion technique
The role of perlinhibin in nucleation and growth of calcium
carbonate crystals was investigated with the ammonium car-
bonate vapor diffusion technique. Scanning electron micro-
scope investigation showed that, in the absence of protein,
only calcite rhombohedra of ;20 mm in size were formed
(Fig. 8 A). When crystallization was carried out in the
presence of perlinhibin (0.02 mg/ml), crystals and crystal
aggregates of different sizes (from ;10 to 100 mm) formed
FIGURE 6 Consecutive AFM images of geological calcite surface cleaved along the [4 4 1] plane. (A) Calcite surface imaged in deionized water, dissolution
of the crystal is visible. (B–J) Frames 3-min apart, consecutive images of the same calcite surface incubated with a 7.5 mMCaCl2 solution containing perlinhibin
(0.02mg/ml). Perlinhibin binds speciﬁcally to calcite steps preventing the dissolution of the calcite layerswhere it is bound. In 7.5mMCaCl2 solution, the surface
of a calcite crystal dissolves slowly. As single perlinhibin molecules bind to the steps (white spots), they protect the binding region against further dissolution;
however, this dissolution continues at sites without bound protein, leading to frayed ridges. Height scale: black to white, 4 nm.
FIGURE 5 XRD diffraction pattern of geological calcite
incubated for 20 h with a saturated CaCO3 solution
(pH 8.2) containing perlinhibin (0.02 mg/ml). The pres-
ence of the aragonite peak indicates that perlinhibin in-
duced formation of aragonite on the calcite substrate. The
formation of aragonite can only be due to perlinhibin,
because formation of aragonite at room temperature and in
the absence of magnesium ions or other additives is never
observed. The peaks corresponding to mica, a silicate, were
caused by the sample holder.
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(Fig. 8, B–E). Crystals were characterized by a rhombohe-
dral-cubic habit. This morphology, similar to that of calcite
crystals, suggested that mainly the most thermodynamically
stable polymorph nucleated. The crystal faces appeared
highly corrugated; the nucleation of new layers with an ir-
regular, convoluted shape took place on the preexisting layers.
The crystals showed the presence of deep pits, suggesting
that perlinhibin inhibited the crystal growth at the binding
sites and that crystallization was only possible around the
surface covered by perlinhibin. Due to the lack of material, it
was not possible to study the inﬂuence of perlinhibin-related
protein on calcium carbonate crystallization.
DISCUSSION
To understand the growth of nacre, which takes place in an
extracellular space delimited by a preformed organic matrix,
it seems promising to identify and purify the major organic
components of the organic matrix and to study their effect on
calcium carbonate crystallization. In the course of our on-
going search for new matrix components, we isolated a small
matrix protein with previously unknown amino-acid se-
quence. Because of its inhibitory effect on calcium carbonate
crystallization the protein was named perlinhibin. In contrast
to other biomineralizing proteins from abalone nacre sequenced
FIGURE 7 Atomic force microscopic image of a calcite surface incubated with perlinhibin. Perlinhibin is bound at some spots of the step ridges of
monomolecular layers. Perlinhibin appears as very small spots of a height of;0.6–0.8 nm (see lower line plot on the right side). The open line marks an edge
without bound perlinhibin, the black line marks an edge with bound perlinhibin. The black line is drawn directly over a bound protein molecule. The
corresponding line plots are shown at the right side. The upper line plot shows the height of a monomolecular step at the calcite crystal surface. The step height
is;0.35 nm, which corresponds nicely to the actual value of 0.32 nm and shows that the instrument is well calibrated. The lower line plot drawn over a bound
perlinhibin molecule shows a height of ;0.5 nm for the perlinhibin binding site.
FIGURE 8 SEM images of calcium
carbonate crystals precipitated using the
ammonium carbonate method in the
absence (A) or presence (B–F) of perlin-
hibin. (A) Dishes containing 7.5 mM
CaCl2 solution (pH 7.5) in an airtight
desiccator were exposed to ammonium
carbonate vapor for ﬁve days at room
temperature. The precipitated crystals
grew with the typical morphology of
geological calcite. (B–F) Dishes with 7.5
mM CaCl2 solution (pH 7.5) containing
perlinhibin (0.02 mg/ml of protein) in an
airtight desiccator were exposed to am-
monium carbonate vapor for ﬁve days at
room temperature. Perlinhibin caused
inhibition of crystal growth at the binding
site. The precipitated crystals showed
many steps andholes. (F)Hole formation
caused by adhesion of perlinhibin can
be observed at higher magniﬁcation.
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before, the sequence of this new protein did not belong to a
previously known family and did not include a known motif
such as the C-type lectinlike domain of perlucin (11), the
IGF-binding domain of perlustrin (12), or the whey acidic
protein domains of perlwapin (13). However, abalone nacre
also contained a perlinhibin-related protein showing a
sequence identity of 67.5% to perlinhibin, indicating that
these new small proteins may belong to a family of closely
relatednacrematrix proteins.While a database search with the
new sequences was not very productive, the comparison to
a group of small synthetic peptides binding to aragonite (6),
the calcium carbonate polymorph occurring in nacre, was
potentially interesting (Fig. 3 C). The stretch of protein se-
quence similar to this aragonite-binding peptide may be
part of a mineral-binding motif of perlinhibin. Our results
showed that nacre matrix proteins interacting with the
mineral phase need not necessarily be highly acidic. Prob-
ably the proper spacing of positively charged and nega-
tively charged residues and of histidine, which has a pKa
of the side chain near 6 and is protonated only to a low
extent at neutral pH, is more important than overall acidity.
AFM experiments on a calcite surface showed that
perlinhibin speciﬁcally bound to calcite steps whereas, on
the monomolecular faces, only unbound perlinhibin (visible
as small dots) was observable, with positions changing in
consecutive images taken of the same spot. Because of this
step adsorption of the protein, the dissolution and growth
mechanism of the calcite surface, which takes place by
movement of steps, was highly altered. Dissolution of the
crystal was inhibited at the binding sites, leaving a frayed
surface (Figs. 5 and 6) and the growth of calcite was con-
sistently inhibited at the protein-binding sites (Fig. 4) causing
the formation of holes. These observations were supported
by crystallization experiments performed with the ammo-
nium carbonate vapor diffusion technique in presence of
perlinhibin. Crystals were obtained which, morphologically,
roughly resembled calcite. The surface of these crystals was
covered with pits presumably due to perlinhibin binding.
New layers were nucleated possibly because of the distur-
bance that was caused by the perlinhibin binding.
XRD investigation of a calcite crystal after AFM inves-
tigations with a supersaturated calcium-carbonate solution in
presence of perlinhibin showed that the crystal overgrowth
consisted of aragonite. Before, only the mixture of water-
soluble nacre proteins was known to cause such a transition
(18), but until now no isolated abalone nacre protein was
identiﬁed to cause this polymorph change. A possible but
speculative explanation for these ﬁndings might be that
perlinhibin speciﬁcally inhibits calcite growth by making the
growth energetically unfavorable, and thus indirectly pro-
motes the growth of aragonite (the third water free calcium
carbonate polymorph, vaterite, usually only develops upon
rapid crystallization).
The possible role of inhibitory proteins like perlinhibin
or perlwapin in abalone nacre formation might be the pre-
vention of uncontrolled mineralization of calcite inside the
extrapallial ﬂuid. Other organic matrix components like
perlucin and the water-insoluble organic matrix, which forms
a three-dimensional framework before mineralization, are
responsible for nucleation and spatial alignment of crystal-
lization (19). However, it is likely that in nature, the situation
is more complex, and at least some of the organic components
have multiple roles; for example, modulation of crystalliza-
tion and connection of mineral and organic components.
The protein sequence data reported in this work will appear in the Uniprot
Knowledgebase under the accession numbers P85035 (perlinhibin) and
P85036 (perlinhibin-related protein).
We are grateful to Fabienne Bosselmann, University of Duisburg-Essen,
Germany, who performed the x-ray diffraction measurements.
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